Honesty and accountability is everything to us. We cherish the trust we have in each other as a team and the confidence our partners have in us.
We hire people who make us excited to come to work.
Tracey Mullen is a chemical-biological engineer from MIT who began her career as an Antibody Discovery Scientist at a startup contract research organization specializing in in vivo antibody discovery. Before bringing her talent to Abveris, she helped implement the technology transfer of the Adimab yeast display platform for antibody discovery and engineering at Biogen. Throughout her tenure at Biogen, Tracey worked to optimize the in vitro discovery of antibodies to tough targets, including leveraging the Adimab platform to generate antibodies against GPCRs.
Colby provides scientific leadership for the team to guide decisions and develop innovative strategies for successful delivery of each unique project. Before Abveris, he graduated with a Ph. D. in Cell and Molecular Biology from Texas A&M and directed antibody discovery and engineering programs at both MassBiologics of the University of Massachusetts Medical School and Kanyos Bio.
Garren is a passionate leader, entrepreneur, and antibody enthusiast. Before co-founding Abveris, Garren began his career building Abpro, a start-up CRO specializing in the in-vivo generation of monoclonal antibodies to support drug discovery research. Following this, he led the biotherapeutics discovery BD function at Dyax, managing collaborations using the at-the-time leading phage display mAb discovery platform. When he's not in the office, Garren enjoys spending time with his wife and young son, hiking, camping, fishing, and playing tennis.
Ryan is a graduate of the Harvard Department of Molecular and Cellular Biology and hire #1 at Abveris. Ryan consults across diverse antibody discovery projects, bridging science and business development. In his free time, Ryan can be found hiking or skiing in hard to reach places around the White Mountains.